Cells reactivate compromised DNA replication forks using enzymes that include DNA helicases for separating DNA strands and remodelling protein-DNA complexes. HelQ helicase promotes replication-coupled DNA repair in mammals in a network of interactions with other proteins. We report newly identified HelQ helicase activities, when acting alone and when interacting with RPA. HelQ helicase was strongly inhibited by a DNA-protein barrier (BamHI 
INTRODUCTION
DNA replication is essential for the cell cycle of prokaryotes and eukaryotes, and relies on DNA repair and genome stability enzymes to ensure that genome duplication is completed with high fidelity. Encounters of the replisome, the multi-enzyme machine that synthesises new DNA, with chemical damage to DNA or DNA-bound protein complexes stresses DNA replication causing it to halt or collapse and provoking genome instability (1) (2) (3) . To overcome these problems cells utilize multiple "skipping" and "restart" mechanisms to resume DNA replication according to the disposition of the problem encountered, recently reviewed (4).
DNA replication thwarted by DNA strand breaks can be restarted by homologous recombination, dependent on a strand invasion reaction catalysed by recombinases and their mediator proteins (5) (6) (7) (8) (9) . Recombination events subsequent to strand invasion take a variety of guises leading to renewed DNA synthesis and reloading of the replisome (10) . Replisome blocking lesions on leading or lagging strand templates of the replication fork in E. coli can be overcome by "skipping" the problem and re-priming replication downstream of the lesion leaving, ssDNA gaps for repair (11, 12) . In eukaryotes a lagging strand block or lesion is overcome by re-priming of DNA synthesis using Pol α (13) but mechanisms to resume blocked leading strand synthesis are less clear. Leading strand synthesis re-primed beyond a DNA lesion (e.g. a cyclobutane pyrimidine dimer) is inefficient, is inhibited by the single strand DNA (ssDNA) binding protein RPA, and may primarily occur by processes other than those catalysed by Pol α (13).
Human HelQ -RPA roadblock removal proteins of the Fanconi anaemia (FA) complementation group (21,22) and non-FA enzymes including HelQ helicase (originally identified as mus301) (23-26) and its homologous helicasepolymerase PolQ (mus308) (27) (28) (29) . Loss of HelQ in ovarian cells is associated with cancer (25) and expression of HelQ is a marker for resistance to chemotherapy in ovarian cancers (30, 31) . HelQ localises to replication forks when cells are stressed by camptothecin (32) , and physically interacts with ATR, the FA family proteins FancD2/FancI, RPA70 single strand DNA (ssDNA) binding protein, and with a Rad51 paralogue complex comprising Rad51B, Rad51C, Rad51D and XRCC2 (BCDX2) (23, 25) . Interaction between C. elegans HelQ and Rad51 recombinase dissociates Rad51 from duplex DNA independently of HelQ ATPase or helicase activity (33) , which may promote DNA replication fork repair and reactivation without recourse to later stages of homologous recombination (34, 35) .
HelQ is a ssDNA-dependent ATPase that translocates ssDNA with 3' to 5' polarity (26) and unwinds DNA duplexes within a variety of forked and other branched DNA substrates (32) .
Sequence orthologues and homologues of HelQ are present throughout mammals, protozoans and plants. Activities of archaeal homologues (Hel308 or Hjm) have been described in several species (36-41).
Here we investigated ATP-dependent DNA helicase activities of human HelQ, in particular its association with ssDNA binding protein RPA. We report that interaction of HelQ with RPA stimulates DNA unwinding through a protein-DNA barrier, and that interaction of RPA with a non-catalytic, non-DNA binding fragment of HelQ modulates RPA-DNA binding. The data suggests that assembly of an RPA-HelQ complex on ssDNA recruits HelQ to sites of stressed replication, and generates the means to remove other DNA-bound proteins by unwinding DNA as an RPA-HelQ complex.
Human HelQ -RPA roadblock removal RESULTS HelQ helicase is blocked by chemical modifications to DNA and by protein-DNA barriers. Figure S1A) is a single-stranded DNA (ssDNA) -dependent ATPase that unwinds model forked DNA by loading onto 3' tailed ssDNA and translocating with 3' to 5' polarity (26), summarised in Supplementary Figures S1B and S1C using protein purified for this work. We set out to learn more about how ATP-dependent translocation and helicase activities of human HelQ might promote DNA replication coupled repair. For ssDNA translocation we began by incorporating single chemical modifications into Figure S2C) . Pre-incubation of BamHI E111A with Fork-B reduced HelQ unwinding activity from a mean of 52% to 9 -20% using BamHI at 80 or 160
Purified human HelQ protein (Supplementary
Human HelQ -RPA roadblock removal 6 nM ( Figure 1B) , conditions when BamHI E111A bound all fork DNA substrate. HelQ alone is weakly active at translocating through this nucleoprotein complex.
HelQ and RPA, but not RPA Aro1 or E. coli SSB, jointly unwind DNA through a protein barrier.
HelQ forms a complex with the RPA70 (RPA1), the ssDNA binding subunit of heterotrimeric RPA complex (43,44), when pulled-down from human cells (23), and co-localises with RPA foci in camptothecin treated human U20S cells (32) . Consistent with this, RPA interacted with purified human HelQ immobilised on streptactin beads in the absence of DNA (Figure 2A ). We also observed evidence for a stable ternary complex between heterotrimeric RPA, HelQ and DNA in EMSAs ( Figure 2B ). DNA EMSAs of either HelQ or RPA heterotrimer alone mixed with fork-A gave well-defined protein-DNA complexes, summarised in Figure 2B lanes 2 -5.
Addition of HelQ to fork-A pre-bound with RPA generated a clearly defined ternary "super- Previous studies showed that human RPA stimulates HelQ to unwind duplex DNA and that this is not due to RPA preventing re-annealing of dissociated DNA strands (26,32). We observed that RPA stimulated HelQ to overcome the BamHI E111A blockage to helicase activity ( Figure 2C and 2D and supplementary data). HelQ (160 nM) combined with RPA (5 nM) restored maximal fork DNA unwinding, a six-fold increase, to levels observed in the absence of BamHI E111A ( Figure 2C ). Addition to HelQ helicase reactions of E. coli SSB or a DNA binding defective RPA mutant protein (RPA Aro1 ) did not stimulate HelQ to unwind DNA through BamHI E111A ( Figure 2D and Supplementary Figure S3B Figure S3D) , and that RPA did not stimulate HelQ ATPase activity (Supplementary Figure S3E) . We also assessed if RPA stimulates HelQ helicase to dissociate DNA within a G4 Quadruplex after loading onto a 15-nucleotide polyA 3' ssDNA tail, a substrate that is unwound weakly by HelQ alone compared to bacterial RecQ (Supplementary Figure S3F) . RPA had no stimulatory effect on HelQ unwinding G4 DNA, or on unwinding through the abasic site shown in Figure 1 (Supplementary Figure S3G) . These observations indicate that a physical interaction between RPA and HelQ mediates helicase unwinding through a protein-DNA complex.
A non-catalytic N-HelQ domain interacts with RPA and modulates RPA-DNA binding.
We next used purified fragments of HelQ protein to better understand how HelQ and RPA interact. We focussed on using purified HelQ winged helix domain (WHD)(41), based on known and Supplementary Figure S4B ). Apparent destabilisation of RPA-DNA binding by N-HelQ was also observed when RPA was bound to 50-nucleotide ssDNA instead of fork, and when magnesium was included in buffers and EMSA gels instead of EDTA (Supplementary Figure   S4C ). We propose that interaction of the N-terminal region of HelQ with RPA has evolved to modulate RPA-DNA binding in a way that promotes HelQ helicase activity.
HelQ dimerises on ATP binding.
Protein expression constructs used in this work encoded HelQ monomers of 141 KDa, which includes tandem N-terminal streptactin and (His-) 6 affinity tags ( Figure S1A ). Analytical gel filtration (AGF) of purified HelQ protein gave a major HelQ peak corresponding to high molecular mass species (>670 kDa, peak 1 in Figure 4A ). This agrees with the study first characterising purified human HelQ helicase, which identified a 600-kDa HelQ protein peak by gel filtration in buffers in the absence of ATP-Mg 2+ (26). This was confirmed using SEC-MALS of HelQ in the same buffer, which gave a protein mass of 598 kDa ( be analogous to a "fork-clearing role" described for bacterial UvrD, which removes proteins from sites of stalled replication in order to establish fork repair and fork reversal processes (55, 56) . We observed using SEC-MALS that HelQ is helicase active as a protein of 265 kDa when bound to ATP-Mg 2+ , consistent with being a dimer. The N-HelQ fragment was monomeric and therefore dimerization must require interaction between HelQ helicase domains that comprise the remainder of the protein. The implications of dimerization to HelQ translocation mechanism and a role in replication-coupled repair will need detailed assessment using kinetics and biophysical techniques, but we note that helicase domains of DNA polymerase theta (PolQ), a close sequence homologue of HelQ, form a dimer of dimers (57) and that UvrD (58, 59) and RecQ form multimers in response to binding specific DNA structures (60) .
METHODS

DNA substrates
DNA substrates are detailed in Supplementary Data Figure S6 . Unmodified DNA oligonucleotides were purchased from SIGMA and were Cy5 labelled on 5' ends as indicated in Unless stated, enzymes for DNA manipulations were bought from New England Biolabs (NEB).
Fork DNA substrates were made by annealing to room temperature overnight a 1.2:1 ratio of unlabelled: Cy5-labelled complementary oligonucleotides, after heating at 95 o C for 10 minutes.
DNA substrates were separated from unannealed oligonucleotides by gel electrophoresis through 10% w/v acrylamide Tris.HCl, borate and EDTA (TBE) gels, followed by excision of the desired substrate as a gel slice gel and soaking the slice overnight into Tris.HCl pH 7.5 + 150 mM NaCl to recover DNA. G4 Quadruplex was formed from a 50mer oligonucleotide following the method in (61), 3' end-labelled using Aminoallyl-UTP-Cy5 (Jena Bioscience) incubated with
TdT.
Proteins
HelQ and the N-terminal HelQ fragment (N-HelQ) were over expressed using the Bac-to-Bac baculovirus expression system from Gibco BRL in SF9 insect cells, each with N-terminal (His) 6 at -20 o C. Protein concentration was calculated using Bradford's reagent. N-HelQ purification was carried out as described above except that the heparin column step was not included.
Replication Protein A (RPA) was purified at the Research complex in Harwell following previously described methods (62). Marc Wold (University of Iowa) kindly provided purified RPAAro1 protein.
Standard Methods for Protein-DNA assays
Electrophoretic Mobility Shift Assays (EMSAs) were in buffer HB (100 mM Tris pH 7.5, 500 µg/ml BSA and 30% glycerol) containing fresh dithiothreitol (DTT, 25 mM). Protein-DNA reactions were incubated at 37 o C for 10 minutes in 20 µl reaction volumes. Protein dilutions were made resulting in final concentrations described in the results, adding a final volume of 2 µl of protein to reactions. Reactions were loaded directly onto 5% w/v acrylamide TBE gels for electrophoresis at 150 volts for two hours in Protean II tanks in TBE buffer. In EMSA reactions containing RPA and HelQ, RPA was pre-incubated with DNA for 2 min. at room temperature prior to adding HelQ.
Helicase unwinding assays were in the buffer HB buffer supplemented with 5mM magnesium chloride and 5 mM ATP. Cy5 labelled DNA substrate (25 nM) was used with addition of 'coldtrap' unlabelled oligonucleotide to 2.5 nM. Helicase reactions were stopped by addition of buffer STOP comprising 2.5 % w/v SDS, 200 µM EDTA and 2 µg/µl of proteinase K. Reaction products were assessed after electrophoresis through 10% acrylamide TBE gels. Gels were imaged using FLA-3000 or Typhoon machine and quantified using ImageJ, GelEval and Prism software.
BamHI-EIIIA Roadblock Assays
BamHI-EIIIA roadblock experiments were conducted as above with pre-incubation of the substrate with BamHI-EIIIA at described concentrations at room temperature for 15 min. prior to addition of reaction components and HelQ protein. Experiments including RPA were carried out with an additional incubation step prior to addition of HelQ with RPA at described concentrations at 37 o C for 10 min.
Analysis of N-HelQ in structural databases
The amino acid sequence of N-HelQ was confirmed by mass spectrometry and the tertiary structure of this region was predicted with PHYRE2 (63). Resulting predicted structures were analysed and superimposed with DALI (64) giving a structural homology match for Brr2 PWI from PDB accession 5DCA.
RPA-HelQ protein pull-down assays
Protein pull down assays between HelQ and RPA were carried out using streptactin resin to trap (His) 6 -strep-tagged HelQ in a gravity flow streptactin-sepharose column (IBA solutions).
HelQ and RPA were pre-incubated in a 1:1 molar ratio on ice for 30 minutes in buffer comprising 50mM Tris pH7.5, 10% glycerol, 25mM DTT, 150mM NaCl and 0.02% w/v Tween 20. Proteins were applied to streptactin columns equilibrated in the same buffer at 4 o C, with flow-through samples being collected and re-applied to the column three times for maximal HelQ binding. Columns were then washed with one column volume of equilibration buffer prior to elution of bound HelQ using the same buffer containing 2.5 mM desthiobiotin. Collected samples were analysed by SDS-PAGE 8% w/v acrylamide gels.
Analysis of HelQ by size exclusion chromatography and SEC-MALS
Size exclusion chromatography-multi-angle static light scattering (SEC-MALS) was carried out 
